Grhl2 Determines the Epithelial Phenotype of Breast Cancers and Promotes Tumor Progression

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Xiang, Xiaoyu ^b   Deng, ZhongBin ^b   Zhuang, Xiaoying ^b   Ju, Songwen ^b   Mu, Jingyao ^b   Jiang, Hong ^b   Zhang, Lifeng ^b   Yan, Jun ^b   Miller, Donald ^b   Zhang, Huang Ge ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; PROTEIN GRHL2; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER CELL CULTURE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CELL STRAIN MCF10A; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RECURRENCE FREE SURVIVAL;

ANIMALS; BREAST NEOPLASMS; CADHERINS; CELL LINE, TUMOR; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DNA-BINDING PROTEINS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY GLANDS, HUMAN; MICE; NEOPLASM METASTASIS; ORGAN SPECIFICITY; PHENOTYPE; PROTEIN ISOFORMS; RNA-BINDING PROTEINS; TRANSCRIPTION FACTORS; WNT PROTEINS;

EID: 84871312342     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050781     Document Type: Article

References (41)

1. Thiery JP, Acloque H, Huang RYJ, Nieto MA, (2009) Epithelial-Mesenchymal Transitions in Development and Disease. Cell 139: 871-890.
2. Polyak K, Weinberg RA, (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265-273.
3. Thiery JP, Sleeman JP, (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142.
4. Peinado H, Olmeda D, Cano A, (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7: 415-428.
5. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, et al. (2004) Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis. cell 117: 927-939.
6. Xiang X, Zhuang X, Ju S, Zhang S, Jiang H, et al. (2011) miR-155 promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT. Oncogene 30: 3440-3453.
7. Boglev Y, Wilanowski T, Caddy J, Parekh V, Auden A, et al. (2010) The unique and cooperative roles of the Grainy head-like transcription factors in epidermal development reflect unexpected target gene specificity. Developmental Biology 349: 512-522.
8. Yu Z, Bhandari A, Mannik J, Pham T, Xu X, et al. (2008) Grainyhead-like factor Get1/Grhl3 regulates formation of the epidermal leading edge during eyelid closure. Developmental Biology 319: 56-67.
9. Werth M, Walentin K, Aue A, Schönheit J, Wuebken A, et al. (2010) The transcription factor grainyhead-like 2 regulates the molecular composition of the epithelial apical junctional complex. Development 137: 3835-3845.
10. Pyrgaki C, Liu A, Niswander L, (2011) Grainyhead-like 2 regulates neural tube closure and adhesion molecule expression during neural fold fusion. Developmental Biology 353: 38-49.
11. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, et al. (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer cell 10: 515-527.
12. Mani SA, Guo W, Liao M-J, Eaton EN, Ayyanan A, et al. (2008) The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells. Cell 133: 704-715.
13. Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, et al. (2007) Molecular Definition of Breast Tumor Heterogeneity. Cancer cell 11: 259-273.
14. Hoeflich KP, O'Brien C, Boyd Z, Cavet G, Guerrero S, et al. (2009) In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models. Clinical Cancer Research 15: 4649-4664.
15. Hollestelle A, Nagel J, Smid M, Lam S, Elstrodt F, et al. (2009) Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines. Breast Cancer Research and Treatment 121: 53-64.
16. Warzecha CC, Sato TK, Nabet B, Hogenesch JB, Carstens RP, (2009) ESRP1 and ESRP2 Are Epithelial Cell-Type-Specific Regulators of FGFR2 Splicing. Molecular cell 33: 591-601.
17. Györffy B, Lanczky A, Eklund A, Denkert C, Budczies J, et al. (2010) An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Research and Treatment 123: 725-731.
18. Chiu HS, Szucsik JC, Georgas KM, Jones JL, Rumballe BA, et al. (2010) Comparative gene expression analysis of genital tubercle development reveals a putative appendicular Wnt7 network for the epidermal differentiation. Developmental Biology 344: 1071-1087.
19. Winuthayanon W, Hewitt SC, Orvis GD, Behringer RR, Korach KS, (2010) Uterine epithelial estrogen receptor α is dispensable for proliferation but essential for complete biological and biochemical responses. Proceedings of the National Academy of Sciences 107: 19272-19277.
20. Filant J, Zhou H, Spencer TE, (2012) Progesterone Inhibits Uterine Gland Development in the Neonatal Mouse Uterus. Biology of Reproduction 86: 146, 141-149.
21. Gibbons DL, Lin W, Creighton CJ, Rizvi ZH, Gregory PA, et al. (2009) Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes & Development 23: 2140-2151.
22. Park S-M, Gaur AB, Lengyel E, Peter ME, (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes & Development 22: 894-907.
23. Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, et al. (2008) A Double-Negative Feedback Loop between ZEB1-SIP1 and the microRNA-200 Family Regulates Epithelial-Mesenchymal Transition. Cancer Research 68: 7846-7854.
24. Yan W, Cao QJ, Arenas RB, Bentley B, Shao R, (2010) GATA3 Inhibits Breast Cancer Metastasis through the Reversal of Epithelial-Mesenchymal Transition. Journal of Biological Chemistry 285: 14042-14051.
25. Yori JL, Johnson E, Zhou G, Jain MK, Keri RA, (2010) Krüppel-like Factor 4 Inhibits Epithelial-to-Mesenchymal Transition through Regulation of E-cadherin Gene Expression. Journal of Biological Chemistry 285: 16854-16863.
26. Visvader JE, (2009) Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes & Development 23: 2563-2577.
27. Kouros-Mehr H, Bechis SK, Slorach EM, Littlepage LE, Egeblad M, et al. (2008) GATA-3 Links Tumor Differentiation and Dissemination in a Luminal Breast Cancer Model. Cancer cell 13: 141-152.
28. Gumireddy K, Li A, Gimotty PA, Klein-Szanto AJ, Showe LC, et al. (2009) KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer. Nat Cell Biol 11: 1297-1304.
29. Morel A-P, Hinkal GW, Thomas C, Fauvet F, Courtois-Cox S, et al. (2012) EMT Inducers Catalyze Malignant Transformation of Mammary Epithelial Cells and Drive Tumorigenesis towards Claudin-Low Tumors in Transgenic Mice. PLoS Genet 8: e1002723.
30. Scheel C, Eaton Elinor N, Li Sophia H-J, Chaffer Christine L, Reinhardt F, et al. (2011) Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast. Cell 145: 926-940.
31. Bhat-Nakshatri P, Appaiah H, Ballas C, Pick-Franke P, Goulet R, et al. (2010) SLUG/SNAI2 and Tumor Necrosis Factor Generate Breast Cells With CD44+/CD24- Phenotype. BMC Cancer 10: 411.
32. Santisteban M, Reiman JM, Asiedu MK, Behrens MD, Nassar A, et al. (2009) Immune-Induced Epithelial to Mesenchymal Transition In vivo Generates Breast Cancer Stem Cells. Cancer Research 69: 2887-2895.
33. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, et al. (2001) The Two-Handed E Box Binding Zinc Finger Protein SIP1 Downregulates E-Cadherin and Induces Invasion. Molecular cell 7: 1267-1278.
34. Hajra KM, Chen DY-S, Fearon ER, (2002) The SLUG Zinc-Finger Protein Represses E-Cadherin in Breast Cancer. Cancer Research 62: 1613-1618.
35. Warzecha CC, Jiang P, Amirikian K, Dittmar KA, Lu H, et al. (2010) An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition. EMBO J 29: 3286-3300.
36. Korpal M, Ell BJ, Buffa FM, Ibrahim T, Blanco MA, et al. (2011) Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med advance online publication.
37. Celià-Terrassa T, Meca-Cortés Ó, Mateo F, Martínez de Paz A, Rubio N, et al. (2012) Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. The Journal of Clinical Investigation 122: 1849-1868.
38. Dykxhoorn DM, Wu Y, Xie H, Yu F, Lal A, et al. (2009) miR-200 Enhances Mouse Breast Cancer Cell Colonization to Form Distant Metastases. PLoS ONE 4: e7181.
39. Chaffer CL, Thompson EW, Williams ED, (2007) Mesenchymal to Epithelial Transition in Development and Disease. Cells Tissues Organs 185: 7-19.
40. Nguyen DX, Bos PD, Massague J, (2009) Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9: 274-284.
41. Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, et al. (2006) [9] TM4 Microarray Software Suite. Methods in Enzymology: Academic Press. pp. 134-193.